Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial.
BACKGROUND: Infectious complications and associated mortality are a major concern in acute pancreatitis. Enteral administration of probiotics could prevent infectious complications, but convincing evidence is scarce. Our aim was to assess the effects of probiotic prophylaxis in patients with predic...
Auteurs principaux: | Besselink, MG, van Santvoort, H, Buskens, E, Boermeester, M, van Goor, H, Timmerman, H, Nieuwenhuijs, V, Bollen, T, van Ramshorst, B, Witteman, B, Rosman, C, Ploeg, R, Brink, M, Schaapherder, A, Dejong, C, Wahab, P, van Laarhoven, C, van der Harst, E, Eijck, v, Cuesta, M, Akkermans, L, Gooszen, H |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2008
|
Documents similaires
-
[Probiotic prophylaxis in patients with predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial].
par: Besselink, MG, et autres
Publié: (2008) -
Probiotic prophylaxis in patients with predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial
par: Besselink, M, et autres
Publié: (2008) -
Probiotic prophylaxis In predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial
par: Besselink, MG, et autres
Publié: (2009) -
Intestinal barrier dysfunction in a randomized trial of a specific probiotic composition in acute pancreatitis.
par: Besselink, MG, et autres
Publié: (2009) -
Gastrointestinal permeability and infectious complications in acute pancreatitis; a prospective multicenter study
par: Besselink, MG, et autres
Publié: (2008)